Search in:

Advanced search

Leukemia & Lymphoma Volume 60, 2019 - Issue 13

Submit an article Journal homepage

822

Views

CrossRef citations to date

Altmetric

Original Articles

Slow lenalidomide desensitization protocol for patients with multiple myeloma: case series from a single center

Patrick YauDepartment of Pharmacy, Tom Baker Cancer Center, Calgary, AB, Canada;

Victor H. Jimenez-ZepedaDepartment of Medical Oncology and Hematology, Tom Baker Cancer Center, Calgary, AB, CanadaCorrespondence[email protected]

Kyla BaileyDepartment of Pharmacy, Tom Baker Cancer Center, Calgary, AB, Canada;

Peter DugganDepartment of Medical Oncology and Hematology, Tom Baker Cancer Center, Calgary, AB, Canada

Jason TayDepartment of Medical Oncology and Hematology, Tom Baker Cancer Center, Calgary, AB, Canada

Nizar J. BahlisDepartment of Medical Oncology and Hematology, Tom Baker Cancer Center, Calgary, AB, Canada

Paola NeriDepartment of Medical Oncology and Hematology, Tom Baker Cancer Center, Calgary, AB, Canada

Sylvia McCullochDepartment of Medical Oncology and Hematology, Tom Baker Cancer Center, Calgary, AB, Canada

show all

Pages 3199-3203 | Received 13 Jan 2019, Accepted 30 May 2019, Published online: 13 Jun 2019

Cite this article
https://doi.org/10.1080/10428194.2019.1627537
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Reprints & Permissions

References

Revlimid Product Monograph. Summit, NJ: Celgene Corporation. March 2018 Available from: https://media.celgene.com/content/uploads/sites/23/Revlimid-Product_Monograph_-_English_Version.pdf
Google Scholar
Moreau P, Attal M, Facon T. Frontline therapy of multiple myeloma. Blood. 2015;125:3076–3084.
PubMed Web of Science ®Google Scholar
Weber DM, Chen C, Niesvizky R, et al. Lenalidomide plus dexamethasone for relapsed multiple myeloma in North America. N Engl J Med. 2007;357:2133–2142.
PubMed Web of Science ®Google Scholar
Moreau P. How I treat myeloma with new agents. Blood. 2017;130:1507–1513.
PubMed Web of Science ®Google Scholar
McCarthy P, Holstein SA, Petrucci M, et al. Lenalidomide maintenance after autologous stem cell transplant in newly diagnosed multiple myeloma. A meta-analysis. JCO. 2017;35:3279–3289.
PubMed Web of Science ®Google Scholar
Nardone B, Wu S, Garden BC, et al. Risk of rash associated with lenalidomide in cancer patients: a systematic review of the literature and meta-analysis. Clin Lymphoma Myeloma Leuk. 2013;13:424–429.
PubMed Web of Science ®Google Scholar
Barley K, He W, Agarwal S, et al. Outcomes and management of lenalidomide-associated rash in patients with multiple myeloma. Leukemia Lymphoma. 2016;57:2510–2515.
PubMed Web of Science ®Google Scholar
Phillips J, Kujawa J, Davis-Lorron M, et al. Successful desensitization in a patient with lenalidomide hypersensitivity. Am J Hematol. 2007;82:1030.
PubMed Web of Science ®Google Scholar
Seki J, Banglawala S, Lentz E, et al. Desensitization to lenalidomide in a patient with relapsed multiple myeloma. Clin Lymph Myel Leuk. 2013;13:162–165.
PubMed Web of Science ®Google Scholar
Seki J, Sakurai N, Kukreti V. Lenalidomide desensitization in systemic light-chain amyloidosis with multi-organ involvement. J Clin Med Res. 2015;7:807–811.
PubMedGoogle Scholar
Lee M, Wickner P, Fanning L, et al. Lenalidomide desensitization for delayed hypersensitivity reactions in 5 patients with multiple myeloma. Br J Haematol. 2014;167:127–146.
PubMed Web of Science ®Google Scholar
Penna G, Allegra A, Romeo G, etal. Severe dermatologic adverse reactions after exposure to lenalidomide in multiple myeloma patients with a positive HLA-DRB1*1501 and HLA-DQBB1*0602. Acta Oncol. 2012;51:944–947.
PubMed Web of Science ®Google Scholar
Luptakova K, Rosenblatt J, Glotzbecker B, et al. Lenalidomide enhances anti-myeloma cellular immunity. Cancer Immunol Immun. 2013;62:313–325.
Web of Science ®Google Scholar
Scherer K, Brockow K, Aberer W, Gooi J, et al. Desensitization in delayed drug hypersensitivity reactions - an EAACI position paper of the Drug Allergy Interest Group. Allergy. 2013;68:844–852.
PubMed Web of Science ®Google Scholar
Delforge M, Ludwig H. How I manage the toxicities of myeloma drugs. Blood. 2017;129:2359–2367.
PubMed Web of Science ®Google Scholar
Tinsley S, Kurtin S, Ridgewa J. Practical management of lenalidomide-related rash. Clin Lymph Myel Leuk. 2015;S1: S65–S69.
Google Scholar
Pomalyst Product Monograph. Summit, NJ: Celgene Corporation. January 31 2018 Available from: https://media.celgene.com/content/uploads/sites/23/POMALYST_Product_Monograph_English_Version.pdf
Google Scholar
Seki JT, Sakurai N, Lam W, et al. Pomalidomide desensitization in a patient hypersensitive to immunomodulating agents. Curr Oncol. 2017;24:328–e332.
Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Slow lenalidomide desensitization protocol for patients with multiple myeloma: case series from a single center

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Slow lenalidomide desensitization protocol for patients with multiple myeloma: case series from a single center

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date